英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
Consultants查看 Consultants 在百度字典中的解释百度英翻中〔查看〕
Consultants查看 Consultants 在Google字典中的解释Google英翻中〔查看〕
Consultants查看 Consultants 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • LENZ Therapeutics
    LENZ Therapeutics is is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision, focused on an eye drop to treat presbyopia and provide seamless vision for the vast majority of presbyopes
  • LENZ Therapeutics, Inc. (LENZ)
    LENZ Therapeutics is a pharmaceutical company focused on the commercialization of VIZZ™ (aceclidine ophthalmologic solution) 1 44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia To learn more,…
  • Pipeline - Lenz Therapeutics
    LENZ Therapeutics is committed to delivering scientifically innovative solutions to the eye care space We are eager to continue bringing products to market that are in line with our purpose: to free people to forget about their vision
  • About Us | LENZ Therapeutics
    LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision, focused on an eye drop to treat presbyopia and provide seamless vision for the vast majority of presbyopes
  • Company Information - LENZ Therapeutics, Inc.
    LENZ Therapeutics is a pharmaceutical company focused on the commercialization of VIZZ™ (aceclidine ophthalmologic solution) 1 44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia To learn more, please visit www VIZZ com
  • LENZ Therapeutics Announces FDA Acceptance of New Drug Application for . . .
    About LENZ Therapeutics LENZ Therapeutics is a pre-commercial biopharmaceutical company focused on the development and commercialization of the first and only aceclidine-based eye drop to improve near vision in patients with presbyopia LENZ’s product candidate, LNZ100 is a preservative-free, single-use, once-daily eye drop containing aceclidine
  • LENZ Therapeutics Reports Third Quarter 2025 Financial Results and . . .
    LENZ Therapeutics is a pharmaceutical company focused on the commercialization of VIZZ TM (aceclidine ophthalmic solution) 1 44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia, a condition impacting an estimated 1 8 billion people globally and 128 million people in the United States
  • LENZ Therapeutics Reports Second Quarter 2025 Financial Results and . . .
    About LENZ Therapeutics LENZ Therapeutics is a pre-commercial biopharmaceutical company focused on the development and commercialization of the first and only aceclidine-based eye drop to improve near vision in patients with presbyopia LENZ’s product candidate, LNZ100 is a preservative-free, single-use, once-daily eye drop containing aceclidine
  • LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY . . .
    About LENZ Therapeutics LENZ Therapeutics is a late clinical-stage biopharmaceutical company focused on developing the first aceclidine-based eye drop to improve vision in patients diagnosed with presbyopia LENZ’s product candidate LNZ100 is a preservative-free, single-use, once-daily eye drop containing aceclidine
  • Presbyopia | LENZ Therapeutics
    Learn more about the inevitable age-related loss of near vision, how many people it affects, and the mechanisms of action that contribute to blurry near vision





中文字典-英文字典  2005-2009